Journal profile · Multiple
Lancet Regional Health-Europe
ISSN 2666-7762 · Elsevier · United Kingdom
Lancet Regional Health-Europe: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 15.7 (journal website); fully open access; APC about USD 5,800; median 116 days to acceptance (108 articles, last 24 months); 366 articles in 2025; indexed in SCIE, SSCI and Scopus.
Scope
Aims, scope and focus
Lancet Regional Health-Europe is published by Elsevier and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies and Health Systems, Economic Evaluations, Quality of Life, together about 23.8% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
The Lancet Regional Health – Europe is a gold open access journal and part of The Lancet's global initiative to advocate for health-care quality and access in all regions of the world. The journal fosters the advance of clinical practice and health policy in the European region, with the goal of improving health outcomes.The journal publishes high-quality original research that advocates change in, or illuminates, clinical practice and health policy in the European region. The Lancet Regional Health – Europe also features relevant reviews, commentaries, and opinion pieces, pertaining to regional health topics, including but not limited to prevention and management of infections and non-communicable diseases, improvement of healthy ageing, and reduction of health inequalities.
From the journal's Aims & Scope
Research area (LetPub): Multiple
Main research topics OpenAlex counts of recent articles; shares are approximate
- SARS-CoV-2 and COVID-19 ResearchMedicine9.7%
- COVID-19 Clinical Research StudiesMedicine8.3%
- Health Systems, Economic Evaluations, Quality of LifeEconomics, Econometrics and Finance5.9%
- COVID-19 epidemiological studiesMathematics5.8%
- Long-Term Effects of COVID-19Medicine5.7%
- Vaccine Coverage and HesitancySocial Sciences5.5%
- COVID-19 and healthcare impactsMedicine5.3%
- COVID-19 and Mental HealthPsychology4.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Health Care Sciences & Services | Zone 1 |
| Minor | Public, Environmental & Occupational Health | Zone 1 |
Top journal: yesReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Health Care Sciences & Services | Zone 1 |
| Minor | Public, Environmental & Occupational Health | Zone 1 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
SCIESSCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 15.7Publisher website ·
- CiteScore 2026-06
- 19.9LetPub ·
- CiteScore (publisher)
- 19.9Publisher website ·
- SJR 2026-06
- 4.5LetPub ·
- SNIP 2026-06
- 4.05LetPub ·
- h-index
- 90OpenAlex ·
- i10-index
- 727OpenAlex ·
- 2-year mean citedness
- 8.73OpenAlex ·
- Self-citation rate
- 1.3%LetPub ·
- Share of gold OA articles
- 99.82%LetPub ·
Volume
- Articles per year
- 207LetPub ·
Articles by year OpenAlex count · 1,775 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 291 | 291 | 209 |
| 2025 | 366 | 366 | 2,042 |
| 2024 | 361 | 361 | 6,632 |
| 2023 | 228 | 228 | 6,835 |
| 2022 | 250 | 250 | 7,529 |
| 2021 | 266 | 266 | 13,807 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
116 daysMedian, submission to acceptance · P25–P75 65 days – 159 days
- Acceptance to online
- median 17 days (108 articles)
- Submission to online
- median 130 days
- Sample
- 108 articles with submission and acceptance dates (752 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 9 weeksLetPub ·
- Submission to first decision
- 2 daysPublisher website ·
- First decision after review
- 27 daysPublisher website ·
- Submission to acceptance
- 81 daysPublisher website ·
- Acceptance to publication
- 21 daysPublisher website ·
- Submission to publication (journal-reported)
- about 21 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 5,800 | Yes | CC BY, CC BY-NC, CC BY-NC-ND | |
| OpenAlex | USD 4,930 / EUR 4,610 / GBP 3,950 / JPY 611,470 | — | — | |
| LetPub | USD 4,000 | Yes | — | |
| Publisher website | USD 5,800 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteOpen access
- Open access Open Access
Article Publishing Charge (APC): USD 5,800 (excluding taxes). Review this journal’s open access policy.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 2666-7762
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Lancet Regional Health-Europe
What CAS zone is Lancet Regional Health-Europe in?
In the 2025 upgraded edition of the CAS Journal Ranking, Lancet Regional Health-Europe is in Zone 1 of Medicine, and in Zone 1 of the minor category Health Care Sciences & Services / Public, Environmental & Occupational Health; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Lancet Regional Health-Europe?
The journal's website gives an impact factor of 15.7; this is the journal's own figure, as LetPub lists none for it; CiteScore 19.9, h-index 90.
How long does peer review take at Lancet Regional Health-Europe?
Based on the dates recorded on 108 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 116 days (interquartile range 65–159 days); authors report an average review time of about 9 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Lancet Regional Health-Europe?
According to LetPub and DOAJ records, Lancet Regional Health-Europe is indexed in SCIE, SSCI, Scopus and DOAJ.
Is Lancet Regional Health-Europe open access, and what is the APC?
Lancet Regional Health-Europe is a fully open-access journal. APC about USD 5,800.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .